Daunorubicin and pneumonia Patient Reports February 11, 2012



Daunorubicin Side Effects Report #4563051-2
Daunorubicin side effect was reported by a Consumer or non-health professional from on July 06, 2004. Male patient, 59 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: chronic myeloid leukaemia, leukaemia recurrent, pneumonia What is  pneumonia. Daunorubicin dosage: unknown. During the same period patient was treated with MITOXANTRONE, CYTARABINE, ETOPOSIDE, MERCAPTOPURINE, VINDESINE. Patient died.

Daunorubicin Side Effects Report #4568114-3
Daunorubicin side effect was reported by a Consumer or non-health professional from on July 06, 2004. Male patient, 59 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: chronic myeloid leukaemia, pneumonia What is  pneumonia, skin disorder. Daunorubicin dosage: unknown. During the same period patient was treated with MITOXANTRONE, CYTARABINE, ETOPOSIDE, MERCAPTOPURINE, VINDESINE. Patient died.

Daunorubicin Side Effects Report #4771579-5
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2005. Female patient, weighting 170.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: pneumonia What is  pneumonia. Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, ELSPAR, METHOTREXATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4967638-4
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 07, 2006. Male patient, weighting 186.1 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: influenza, multi-organ failure, pneumonia What is  pneumonia. Daunorubicin dosage: 357 MG. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE SULPHATE, ALLOPURINOL. Patient died on 02/17/2006.


Daunorubicin Side Effects Report #5001627-9
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2006. Male patient, weighting 177.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: deep vein thrombosis What is  deep vein thrombosis, febrile neutropenia, pneumonia What is  pneumonia, pulmonary embolism What is  pulmonary embolism, pulmonary infarction. Daunorubicin dosage: 462 MG. During the same period patient was treated with ELSPAR, METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5447614-8
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 21, 2007. Male patient, 74 years of age, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: pneumonia What is  pneumonia. Daunorubicin dosage: 50 MG/M2 DAILY IV. During the same period patient was treated with CYTARABINE, GEMTUZUMB. Patient died on 07/13/2007.

Daunorubicin Side Effects Report #5488973-X
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 02, 2007. Male patient, 74 years of age, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: chest discomfort, pneumonia What is  pneumonia. Daunorubicin dosage: 50 MG/M2 DAILY IV. During the same period patient was treated with CYTARABINE, GEMTUZUMAB. Patient died on 07/13/2007.

Daunorubicin Side Effects Report #5727306-8
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 12, 2008. Male patient, 72 years of age, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, pneumonia What is  pneumonia. Daunorubicin dosage: 50 MG/M2 IV. During the same period patient was treated with CLOFARABINE. Patient died on 01/30/2008.

Daunorubicin Side Effects Report #5603882-0
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 25, 2008. Male patient, weighting 175.3 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, back pain What is  back pain, fluid overload, influenza like illness, pneumonia What is  pneumonia, respiratory failure, tooth abscess. Daunorubicin dosage: 188 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.


Daunorubicin Side Effects Report #5636218-X
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2008. Female patient, weighting 233.7 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, blood ph decreased, neutropenia, pco2 increased, pneumonia What is  pneumonia, po2 increased, refusal of treatment by relative, renal failure acute. Daunorubicin dosage: 95 MG. During the same period patient was treated with ELSPAR, VINCRISTINE SULPHATE, AZITHROMYCIN, CEFEPIME, FILGRASTIM, HUMULIN, MAGNESIUM SULPHATE, METRONIDAZOLE. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Daunorubicin